Development of AB-2100, an autologous integrated circuit T (ICT) cell therapy targeting CA9 intended for the treatment of ccRCC.
- Resource Type
- Article
- Authors
- Landon, Mark; Scarfo, Irene; Chew, Marvin; Sudhakah, Rakesh; Nguyen, Michelle; Mohanty, Suchismita; Chen, Jeremy; Gomez, Alma; Attanasio, Nickolas; Fearon, Amanda; Chan, Ivan; Sail, Vibhavari; Gardner, Thomas; Millare, Beatriz; Thomas, Vince; Zhou, Stanley; Smith, Jenessa; Mcdevitt, Jennifer; Boroughs, Angela; Gray-Rupp, Levi
- Source
- Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p472-472, 140p
- Subject
- Language
- ISSN
- 0732183X